Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Life Insurance

AEGON to Drop U.S. BOLI, COLI Lines

By Trevor Thomas

X
Your article was successfully shared with the contacts you provided.

AEGON N.V. says it will stop selling bank-owned life insurance and corporate-owned life insurance (BOLI-COLI) in the United States and close down its BOLI-COLI operations in Louisville, Ky.

AEGON, The Hague, Netherlands (NYSE:AG), says it also will discontinue new sales of nonqualified executive benefit plans.

The company is making the moves to focus on core activities and improve the efficiency of its U.S. operations, according to Mark Mullin, chief executive officer of AEGON Americas, Cedar Rapids, Iowa.

Most of the BOLI and COLI unit employees are in Dallas.

Office closings in Louisville and elsewhere could lead to the elimination of about 400 to 500 U.S. jobs over the next 2 years, or about 5% of all AEGON jobs in the United States, the company says.

The cutbacks will result in a restructuring charge of about $80 million and a $210 million write-off of goodwill and other intangible assets, AEGON says.

AEGON is the parent company of Transamerica, Los Angeles. The company expanded its BOLI and COLI operations by agreeing to pay about $293 million to acquire Clark Inc., Barrington, Ill., in 2007. AEGON increased the price to $304 million before it completed acquisition.

- Trevor Thomas

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.